Alexion acquiring bone disease company Enobia for $610 million up front plus milestones

Enobia Pharma Inc.

Canada / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Alexion Pharmaceuticals Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

$18,198.8m on 12/31/2012 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed